Melanie Field is the Executive Director of Cardiometabolic Health at Eli Lilly and Company. Previously, they held various roles within the company, including Director of Ethics & Compliance for NAPAC and Immunology Business Unit Leader for ANZ. From 2009 to 2012, Melanie served as Sales Manager at Eli Lilly Australia. Their extensive experience in the healthcare industry highlights a strong background in leadership and compliance.
This person is not in the org chart
This person is not in any teams
This person is not in any offices